Page last updated: 2024-10-23

bumetanide and Glomerulonephritis, Membranous

bumetanide has been researched along with Glomerulonephritis, Membranous in 1 studies

Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.

Research Excerpts

ExcerptRelevanceReference
"Kidney biopsy demonstrated a membranous nephropathy with predominant staining for C1q."1.38Membranous nephropathy with predominance of C1q: another variant of C1q nephropathy? ( Deurwaarder, ES; Hoogeveen, EK; Steenbergen, EJ; Wetzels, JF, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deurwaarder, ES1
Steenbergen, EJ1
Hoogeveen, EK1
Wetzels, JF1

Other Studies

1 other study available for bumetanide and Glomerulonephritis, Membranous

ArticleYear
Membranous nephropathy with predominance of C1q: another variant of C1q nephropathy?
    Clinical nephrology, 2012, Volume: 77, Issue:6

    Topics: Adult; Biopsy; Bumetanide; Complement C1q; Diuretics; Glomerulonephritis, Membranous; Humans; Kidney

2012